| [1] | Hoerster R,Muether PS,Vierkotten S,et al.Upregulation of TGF-μ1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition[J].Graefes Arch Clin Exp Ophthalmol,2014,252(1):11-16. |
| [2] | Omwandho CO,Konrad L,Halis G,et al.Role of TGF-β in normal human endometrium and endometriosis[J].Hum Reprod,2010,25(1):101-109. |
| [3] | Nagineni CN,Cherukuri KS,Kutty V,et al.Interferon-γ differentially regulates TGF-β1 and TGF-β2 expression in human retinal pigment epithelial cells through JAK-STAT pathway[J].Cell Physiol,2007,210(1):192-200. |
| [4] | Stocks SZ,Taylor SM,Shiels IA.Transforming growth factor-β1 induces α-smooth muscle actin expression and fibronectin synthesis in cultured human retinal pigment epit[J].Clin Experiment Ophthalmol,2001,29(1):33-37. |
| [5] | Winkler J,Hoerauf H.TGF-β and RPE-derived cells in taut subretinal strands from patients with proliferative vitreoretinopathy[J].Eur J Ophthalmol,2011,21(4):422-426. |
| [6] | Matsumoto Y,Takahashi M,Ogata M.Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy[J].Jpn J Ophthalmol,2002,46(4):406-412. |
| [7] | Ochiai Y,Ochiai H.Higher concentration of transforming growth factor-β in aqueous humor of glaucomatous eyes and diabetic eyes[J].Jpn J Ophthalmol,2002,46(3):249-253. |
| [8] | Spranger J,Pfeiffer AF.New concepts in pathogenesis and treatment of diabetic retinopathy[J].Exp Clin Endocrinol Diabetes,2001,109(Suppl 2):S438-S450. |
| [9] | Chiarelli F,Santilli F,Mohn A.Role of growth factors in the development of diabetic complications[J].Horm Res,2000,53(2):53-67. |
| [10] | Raul AP,Janice AJ,Bert MG.Effects of TGF-β and TGF-β neutralizing antibodies on the fibroblast-induced collagen contraction implications for Proliferative vitreoretinopathy[J].Invest Ophthalmol Vis Sci,1994,35(7):2801-2807. |
| [11] | Chen X,Xiao W,Liu X,et al.Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells[J].Curr Mol Med,2014,14(4):523-534. |
| [12] | Corderio MF,Gay JA,Khaw PT.Human anti-transforming growth factor β2 antibody:a new glaucoma anti-scaring agent[J].Intest Ophthalmol Vis Sci,1999,40(10):2225-2234. |
| [13] | Oshima Y,Sakamoto T,Hisatomi T,et al.Gene transfer of soluble TGF-β type Ⅱ receptor inhibits experimental proliferative vitreoretinopathy[J].Gene Ther,2002,9(18):1214-1220. |